Where does Cardioflow Technologies, Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cardioflow Technologies, Llc ranks #24,062 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cardioflow Technologies, Llc hold?

Cardioflow Technologies, Llc holds 11 US utility patents granted between 2017 and 2025, spanning 3 technology areas.

What is Cardioflow Technologies, Llc's Innovation Score?

Cardioflow Technologies, Llc has an Innovation Score of 27.5 out of 100 (top 76% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cardioflow Technologies, Llc's patent grant rate increasing or decreasing?

Cardioflow Technologies, Llc's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Cardioflow Technologies, Llc's patents?

Cardioflow Technologies, Llc's patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cardioflow Technologies, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cardioflow Technologies, Llc

Q: What technology areas does Cardioflow Technologies, Llc focus on?

Cardioflow Technologies, Llc's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 11 patents. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardioflow ranks #24,062 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,062
of 50,000 US assignees by volume: Top 76%
by Innovation Score (27.5/100): 19.4
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24062 · US Corporation #24,062 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,062/50,000
PHOTO-FINISH CALICO COTTAGE
CPC-NARROW A61N · 3 areas
INNOV-THIN 27.5/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Calico Cottage, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Avanti Orthopaedics · near

27
Cardioflow · this assignee

27
Mtekvision · near

27
MTI Wireless EDGE · near

27
Worldwise · near

27
3D Lighting Innovati… · lowest

7

What this shows Cardioflow's Innovation Score is 27.5/100 (top 76% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cardioflow's grants concentrate

Cardioflow Technologies, Llc is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2017. By volume, Cardioflow sits between Calico Cottage, Inc. and CB Therapeutics, Inc..

Cardioflow's three-year grant acceleration

Cardioflow Technologies, Llc shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Calico Cottage

11
CANE' S P A

11
Canon Precision

11
Carbice

11
Cardiologs SAS

11
Carimali S P A

11
Carponovum AB

11
CB Therapeutics

11
Cardioflow ◀

11

What this shows Cardioflow holds 11 patents at rank #24,049, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardioflow

By rank, the assignees closest to #24,049 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cardioflow's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardioflow, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (27 here).

Avanti Orthopaedics Llc 27 Mtekvision Co., Ltd. 27 Worldwise, Inc. 27 MTI Wireless EDGE Ltd. 27

Cardioflow's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 Top 76% higher than 24% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Cardioflow Technologies, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2018	2	18.2%
2019	2	18.2%
2021	4	36.4%
2024	1	9.1%
2025partial year	1	9.1%

Which technologies does Cardioflow Technologies, Llc patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 11

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 8

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 8

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#24,062

of 50,000 tracked assignees

Innovation Score

27.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.